333. Targeted Repair of IL2Rγ Locus in Vitro in Murine Model of X-Linked SCID

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)35346-1
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Selective Growth Advantage of Wild-Type Lymphocytes in X-Linked SCID Recipients

Bone Marrow Transplantation
TransplantationHematology
2002English

Correction:Occurrence of Leukaemia Following Gene Therapy of X-Linked SCID

Nature Reviews Cancer
Cancer ResearchOncology
2003English

Dosage Effect of a Phex Mutation in a Murine Model of X-Linked Hypophosphatemia

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2013English

Two Unique Cases of X-Linked SCID: A Diagnostic Challenge in the Era of Newborn Screening

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2019English

Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1)

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

121. Targeted Gene Therapy in the Treatment of X-Linked Hyper IgM Syndrome

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Transplacental Murine Cytomegalovirus Infection in the Brain of SCID Mice

Virology Journal
VirologyInfectious Diseases
2007English

375 Modelling and Understanding Pathomechanisms of X-Linked Recessive Ichthyosis in Vitro

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

A Murine Model of Targeted Infusion for Intracranial Tumors

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy